Evidence map›Paper›PMID 24495433›Full record

ArticleThe Journal of allergy and clinical immunology2014

Dissecting childhood asthma with nasal transcriptomics distinguishes subphenotypes of disease.

Alex Poole, Cydney Urbanek, Celeste Eng, Jeoffrey Schageman, Sean Jacobson, Brian P O'Connor, Joshua M Galanter, Christopher R Gignoux, Lindsey A Roth, Rajesh Kumar and 7 more

Erratum issuedAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 157 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed, 5 pooled it
10.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

157 citing papers in PubMed, 5 syntheses or guidelines pooled it, 266 citations in OpenAlex.

  1. Long-Term PMAnnals of the American Thoracic Society · 2025
    Pooled it
  2. Differential gene expression in nasal airway epithelium from overweight or obese youth with asthma.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Article
  12. Upper and Lower Respiratory Tract Compartmentalization in Pediatric Stem Cell Transplantation.American journal of respiratory cell and molecular biology · 2026
    Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The PRIMERO birth cohort: Design and baseline characteristics.The journal of allergy and clinical immunology. Global · 2025
    Article
  20. Article

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Alex PooleIntegrated Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo.
Cydney UrbanekIntegrated Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo.
Celeste EngDepartment of Medicine, University of California-San Francisco, San Francisco, Calif.
Jeoffrey SchagemanResearch and Development, Life Technologies, Austin, Tex.
Sean JacobsonDepartments of Epidemiology and Biostatistics, Colorado School of Public Health, Aurora, Colo.
Brian P O'ConnorIntegrated Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo; Integrated Department of Immunology, National Jewish Health and the University of Colorado-Denver, Denver, Colo.
Joshua M GalanterDepartment of Medicine, University of California-San Francisco, San Francisco, Calif; Department of Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, Calif.
Christopher R GignouxDepartment of Medicine, University of California-San Francisco, San Francisco, Calif; Department of Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, Calif.
Lindsey A RothDepartment of Medicine, University of California-San Francisco, San Francisco, Calif.
Rajesh KumarAnn and Robert H. Lurie Children's Hospital of Chicago and the Feinberg School of Medicine, Northwestern University, Chicago, Ill.
Sharon LutzDepartments of Epidemiology and Biostatistics, Colorado School of Public Health, Aurora, Colo.
Andrew H LiuDepartment of Pediatrics, National Jewish Health, Denver, Colo.
Tasha E FingerlinDepartments of Epidemiology and Biostatistics, Colorado School of Public Health, Aurora, Colo.
Robert A SetterquistResearch and Development, Life Technologies, Austin, Tex.
Esteban G BurchardDepartment of Medicine, University of California-San Francisco, San Francisco, Calif; Department of Bioengineering and Therapeutic Sciences, University of California-San Francisco, San Francisco, Calif.
Jose Rodriguez-SantanaCentro de Neumologia Pediatrica, San Juan, Puerto Rico.
Max A SeiboldIntegrated Center for Genes, Environment, and Health, National Jewish Health, Denver, Colo; Department of Pediatrics, National Jewish Health, Denver, Colo; Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado-Denver, Denver, Colo. Electronic address: seiboldm@njhealth.org.
University of California, San Francisco · USColorado School of Public Health · USNational Jewish Health · USUniversity of Colorado Denver · USCentro de Neumologia Pediatrica · PRLurie Children's Hospital · US

Funding

Understanding Asthma EndotypesU19AI077439 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI David J Erle · 2008 to 2026
$41.1M
New Approaches for Empowering Studies of Asthma in Populations of African DescentR01HL104608 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BARNES, KATHLEEN C, KENNY, EIMEAR ELIZABETH · 2011 to 2022
$23.1M
The Airway Functional Genomics of Bronchodilator Drug Response in Minority Children with AsthmaR01HL117004 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AHITUV, NADAV, SEIBOLD, MAX A · 2013 to 2022
$9.3M
CLINICAL, PHARMACOLOGY, DRUG ACTION &PHARMACOKINETICST32GM007546 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Radojka Savic · 1985 to 2026
$8.9M
PHARMACEUTICAL SCIENCES AND PHARMACOGENOMICST32GM007175 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AHITUV, NADAV, KROETZ, DEANNA L · 1985 to 2021
$7.1M
Social Interventions to address disparities In young adult tobacco useP60MD006902 · NIMHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HIATT, ROBERT A · 2012 to 2016
$6.4M
Gene-environments and Admixture in Latino Asthmatics (GALA 2)R01ES015794 · NIEHS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURCHARD, ESTEBAN GONZALEZ · 2008 to 2012
$5.4M
Postdoctoral training in tobacco controlR25CA113710 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLANTZ, STANTON ARNOLD · 2006 to 2015
$5.4M
PHARMACOGENOMICS OF INHALED CORTICOSTEROID RESPONSIVENESS IN PATIENTS WITH ASTHMAR01AI079139 · NIAID · HENRY FORD HEALTH SYSTEM · PI WILLIAMS, KEOKI · 2009 to 2013
$3.9M
Whole Genome Analyses for Asthma in Latino PopulationsR01HL088133 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BURCHARD, ESTEBAN GONZALEZ · 2008 to 2012
$3.8M
Mechanism of Endotoxin's Effect On Allergy RiskR01AI061774 · NIAID · HENRY FORD HEALTH SYSTEM · PI WILLIAMS, KEOKI · 2004 to 2008
$2.9M
VALIDATION OF ADHERENCE DATA--USE IN CLINICAL PRACTICER01DK064695 · NIDDK · HENRY FORD HEALTH SYSTEM · PI WILLIAMS, KEOKI · 2003 to 2010
$2.7M
NCI NIH HHS CA113710NCI NIH HHS R25 CA113710NCI NIH HHS T32 CA113710NHLBI NIH HHS HL078885NHLBI NIH HHS HL079055NHLBI NIH HHS HL088133NHLBI NIH HHS HL104608NHLBI NIH HHS K12 HL090147NHLBI NIH HHS K12HL090147NHLBI NIH HHS K23 HL111636NHLBI NIH HHS R01 HL078885NHLBI NIH HHS R01 HL079055NHLBI NIH HHS R01 HL088133NHLBI NIH HHS R01 HL104608NHLBI NIH HHS R01 HL117004NIAID NIH HHS AI061774NIAID NIH HHS AI077439NIAID NIH HHS AI079139NIAID NIH HHS R01 AI061774NIAID NIH HHS R01 AI079139NIAID NIH HHS U19 AI077439NIDDK NIH HHS DK064695NIDDK NIH HHS R01 DK064695NIEHS NIH HHS ES015794NIEHS NIH HHS R01 ES015794NIGMS NIH HHS T32 GM007175NIGMS NIH HHS T32 GM007546NIMHD NIH HHS P60 MD006902NIMHD NIH HHS P60MD006902
6 · The paper itself

Abstract

backgroundBronchial airway expression profiling has identified inflammatory subphenotypes of asthma, but the invasiveness of this technique has limited its application to childhood asthma.

objectivesWe sought to determine whether the nasal transcriptome can proxy expression changes in the lung airway transcriptome in asthmatic patients. We also sought to determine whether the nasal transcriptome can distinguish subphenotypes of asthma.

methodsWhole-transcriptome RNA sequencing was performed on nasal airway brushings from 10 control subjects and 10 asthmatic subjects, which were compared with established bronchial and small-airway transcriptomes. Targeted RNA sequencing nasal expression analysis was used to profile 105 genes in 50 asthmatic subjects and 50 control subjects for differential expression and clustering analyses.

resultsWe found 90.2% overlap in expressed genes and strong correlation in gene expression (ρ = .87) between the nasal and bronchial transcriptomes. Previously observed asthmatic bronchial differential expression was strongly correlated with asthmatic nasal differential expression (ρ = 0.77, P = 5.6 × 10(-9)). Clustering analysis identified TH2-high and TH2-low subjects differentiated by expression of 70 genes, including IL13, IL5, periostin (POSTN), calcium-activated chloride channel regulator 1 (CLCA1), and serpin peptidase inhibitor, clade B (SERPINB2). TH2-high subjects were more likely to have atopy (odds ratio, 10.3; P = 3.5 × 10(-6)), atopic asthma (odds ratio, 32.6; P = 6.9 × 10(-7)), high blood eosinophil counts (odds ratio, 9.1; P = 2.6 × 10(-6)), and rhinitis (odds ratio, 8.3; P = 4.1 × 10(-6)) compared with TH2-low subjects. Nasal IL13 expression levels were 3.9-fold higher in asthmatic participants who experienced an asthma exacerbation in the past year (P = .01). Several differentially expressed nasal genes were specific to asthma and independent of atopic status.

conclusionNasal airway gene expression profiles largely recapitulate expression profiles in the lung airways. Nasal expression profiling can be used to identify subjects with IL13-driven asthma and a TH2-skewed systemic immune response.

Indexed as

Gene Expression ProfilingAdolescentAsthmaBronchiFemaleGenome-Wide Association StudyHumansInterleukin-13MaleNasal MucosaPhenotypeTh2 CellsInterleukin-13asthmabronchial airway epitheliumNasal airway epitheliumT(H)2transcriptome

Identifiers

PMID24495433
PMCPMC4043390
OpenAlexW1967701134

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.